|
Aurobindo Pharma Ltd.
|
QUARTERLY RESULTS
|
|
|
You can view the
Quaterly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
69411.60 Cr.
|
P/BV
|
2.13
|
Book Value (Rs.)
|
562.21
|
|
52 Week High/Low (Rs.)
|
1356/1010
|
FV/ML
|
1/1
|
P/E(X)
|
19.91
|
|
Bookclosure
|
08/08/2025
|
EPS (Rs.)
|
60.02
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 8236.96 | 7791.77 | 8381.12 | 7893.15 | 7646.21 |
| Other Operating Income | 48.74 | 76.37 | 1.00 | 85.37 | 149.86 |
| Total Income From Operations | 8285.70 | 7868.14 | 8382.12 | 7978.52 | 7796.07 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 2509.80 | 2535.16 | 2799.51 | 2728.74 | 2741.85 |
| Purchase of Traded Goods | 846.05 | 807.80 | 636.18 | 823.89 | 747.03 |
| Increase/Decrease in Stocks | -16.99 | -103.74 | -7.81 | -237.22 | -278.61 |
| Employees Cost | 1277.33 | 1228.80 | 1162.64 | 1131.55 | 1109.48 |
| Depreciation | 429.19 | 405.70 | 444.43 | 418.53 | 382.28 |
| Other Expenses | 1991.41 | 1797.09 | 1999.68 | 1953.58 | 1910.18 |
| Total Expenses | 7036.79 | 6670.81 | 7034.63 | 6819.07 | 6612.21 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 1248.91 | 1197.33 | 1347.49 | 1159.45 | 1183.86 |
| Other Income | 120.59 | 105.30 | 134.81 | 157.29 | 136.00 |
| P/L Before Interest, Excpt. Items & Tax | 1369.50 | 1302.63 | 1482.30 | 1316.74 | 1319.86 |
| Interest | 95.24 | 97.75 | 115.02 | 118.48 | 112.70 |
| P/L Before Exceptional Items & Tax | 1274.26 | 1204.88 | 1367.28 | 1198.26 | 1207.16 |
| P/L Before Tax | 1274.26 | 1204.88 | 1367.28 | 1198.26 | 1207.16 |
| Tax | 427.79 | 382.60 | 432.26 | 354.28 | 390.51 |
| P/L After Tax from Ordinary Activities | 846.47 | 822.28 | 935.02 | 843.98 | 816.65 |
| Net Profit/Loss For the Period | 846.47 | 822.28 | 935.02 | 843.98 | 816.65 |
| Minority Interest | 0.32 | 0.55 | 0.64 | 0.24 | 0.43 |
| Share Of P/L Of Associates | 1.66 | 1.92 | -32.19 | 1.59 | 0.30 |
| Net P/L After Minority Interest & Share Of Associates | 848.45 | 824.75 | 903.47 | 845.81 | 817.38 |
| | | | | | |
| Equity Share Capital | 58.08 | 58.08 | 58.08 | 58.08 | 58.08 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 14.61 | 14.20 | 15.56 | 14.56 | 14.00 |
| Diluted EPS (Rs.) | 14.61 | 14.20 | 15.56 | 14.56 | 14.00 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 14.61 | 14.20 | 15.56 | 14.56 | 14.00 |
| Diluted EPS (Rs.) | 14.61 | 14.20 | 15.56 | 14.56 | 14.00 |
| | | | | | |
| PBITOE Margin (%) | 15.07 | 15.21 | 16.07 | 14.53 | 15.18 |
| PBTE Margin (%) | 15.37 | 15.31 | 16.31 | 15.01 | 15.48 |
| PBT Margin (%) | 15.37 | 15.31 | 16.31 | 15.01 | 15.48 |
| PAT Margin (%) | 10.21 | 10.45 | 11.15 | 10.57 | 10.47 |
| PAT After MI And SOA Margin (%) | 10.23 | 10.48 | 10.77 | 10.60 | 10.48 |
